These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 23115013

  • 1. Recombinant anti-podoplanin (NZ-1) immunotoxin for the treatment of malignant brain tumors.
    Chandramohan V, Bao X, Kato Kaneko M, Kato Y, Keir ST, Szafranski SE, Kuan CT, Pastan IH, Bigner DD.
    Int J Cancer; 2013 May 15; 132(10):2339-48. PubMed ID: 23115013
    [Abstract] [Full Text] [Related]

  • 2. Construction of an immunotoxin, D2C7-(scdsFv)-PE38KDEL, targeting EGFRwt and EGFRvIII for brain tumor therapy.
    Chandramohan V, Bao X, Keir ST, Pegram CN, Szafranski SE, Piao H, Wikstrand CJ, McLendon RE, Kuan CT, Pastan IH, Bigner DD.
    Clin Cancer Res; 2013 Sep 01; 19(17):4717-27. PubMed ID: 23857604
    [Abstract] [Full Text] [Related]

  • 3. Construction, expression, and characterization of an anti-tumor immunotoxin containing the human anti-c-Met single-chain antibody and PE38KDEL.
    Liu Z, Feng Z, Zhu X, Xu W, Zhu J, Zhang X, Fan Z, Ji G.
    Immunol Lett; 2013 Jan 01; 149(1-2):30-40. PubMed ID: 23026237
    [Abstract] [Full Text] [Related]

  • 4. Improved binding and antitumor activity of a recombinant anti-erbB2 immunotoxin by disulfide stabilization of the Fv fragment.
    Reiter Y, Brinkmann U, Jung SH, Lee B, Kasprzyk PG, King CR, Pastan I.
    J Biol Chem; 1994 Jul 15; 269(28):18327-31. PubMed ID: 7913461
    [Abstract] [Full Text] [Related]

  • 5. The improvement of an anti-CD22 immunotoxin: conversion to single-chain and disulfide stabilized form and affinity maturation by alanine scan.
    Kawa S, Onda M, Ho M, Kreitman RJ, Bera TK, Pastan I.
    MAbs; 2011 Jul 15; 3(5):479-86. PubMed ID: 22048691
    [Abstract] [Full Text] [Related]

  • 6. Cytotoxic and antitumor activity of a recombinant immunotoxin composed of disulfide-stabilized anti-Tac Fv fragment and truncated Pseudomonas exotoxin.
    Reiter Y, Kreitman RJ, Brinkmann U, Pastan I.
    Int J Cancer; 1994 Jul 01; 58(1):142-9. PubMed ID: 8014011
    [Abstract] [Full Text] [Related]

  • 7. Immunotoxin treatment targeted to the high-molecular-weight melanoma-associated antigen prolonging the survival of immunodeficient rats with invasive intracranial human glioblastoma multiforme.
    Hjortland GO, Garman-Vik SS, Juell S, Olsen OE, Hirschberg H, Fodstad O, Engebraaten O.
    J Neurosurg; 2004 Feb 01; 100(2):320-7. PubMed ID: 15086240
    [Abstract] [Full Text] [Related]

  • 8. In vitro and in vivo studies of antitumor effects of the recombinant immunotoxin MSH-PE38KDEL on melanoma.
    Hui Q, Ma J, Song J, Liu Z, Ren H, Jiang W, Wang Y, Xu Y, Guo D, Zhang X, Lu S.
    Neoplasma; 2014 Feb 01; 61(4):392-400. PubMed ID: 25027740
    [Abstract] [Full Text] [Related]

  • 9. Anti-PSMA immunotoxin as novel treatment for prostate cancer? High and specific antitumor activity on human prostate xenograft tumors in SCID mice.
    Wolf P, Alt K, Bühler P, Katzenwadel A, Wetterauer U, Tacke M, Elsässer-Beile U.
    Prostate; 2008 Feb 01; 68(2):129-38. PubMed ID: 18044731
    [Abstract] [Full Text] [Related]

  • 10. Preclinical evaluation of a recombinant anti-prostate specific membrane antigen single-chain immunotoxin against prostate cancer.
    Wolf P, Alt K, Wetterauer D, Bühler P, Gierschner D, Katzenwadel A, Wetterauer U, Elsässer-Beile U.
    J Immunother; 2010 Apr 01; 33(3):262-71. PubMed ID: 20445346
    [Abstract] [Full Text] [Related]

  • 11. Recombinant single-chain and disulfide-stabilized Fv-immunotoxins that cause complete regression of a human colon cancer xenograft in nude mice.
    Reiter Y, Wright AF, Tonge DW, Pastan I.
    Int J Cancer; 1996 Jul 03; 67(1):113-23. PubMed ID: 8690511
    [Abstract] [Full Text] [Related]

  • 12. Preclinical development of a recombinant toxin containing circularly permuted interleukin 4 and truncated Pseudomonas exotoxin for therapy of malignant astrocytoma.
    Puri RK, Hoon DS, Leland P, Snoy P, Rand RW, Pastan I, Kreitman RJ.
    Cancer Res; 1996 Dec 15; 56(24):5631-7. PubMed ID: 8971168
    [Abstract] [Full Text] [Related]

  • 13. In vivo efficacy of the recombinant anti-CD64 immunotoxin H22(scFv)-ETA' in a human acute myeloid leukemia xenograft tumor model.
    Tur MK, Huhn M, Jost E, Thepen T, Brümmendorf TH, Barth S.
    Int J Cancer; 2011 Sep 01; 129(5):1277-82. PubMed ID: 21077160
    [Abstract] [Full Text] [Related]

  • 14. Production and quality control assessment of a GLP-grade immunotoxin, D2C7-(scdsFv)-PE38KDEL, for a phase I/II clinical trial.
    Chandramohan V, Pegram CN, Piao H, Szafranski SE, Kuan CT, Pastan IH, Bigner DD.
    Appl Microbiol Biotechnol; 2017 Apr 01; 101(7):2747-2766. PubMed ID: 28013405
    [Abstract] [Full Text] [Related]

  • 15. Targeting tumor-associated macrophages in an experimental glioma model with a recombinant immunotoxin to folate receptor beta.
    Nagai T, Tanaka M, Tsuneyoshi Y, Xu B, Michie SA, Hasui K, Hirano H, Arita K, Matsuyama T.
    Cancer Immunol Immunother; 2009 Oct 01; 58(10):1577-86. PubMed ID: 19238383
    [Abstract] [Full Text] [Related]

  • 16. Interleukin-4 receptor cytotoxin as therapy for human malignant pleural mesothelioma xenografts.
    Beseth BD, Cameron RB, Leland P, You L, Varricchio F, Kreitman RJ, Maki RA, Jablons DM, Husain SR, Puri RK.
    Ann Thorac Surg; 2004 Aug 01; 78(2):436-43; discussion 436-43. PubMed ID: 15276492
    [Abstract] [Full Text] [Related]

  • 17. New immunotoxins targeting CD123, a stem cell antigen on acute myeloid leukemia cells.
    Du X, Ho M, Pastan I.
    J Immunother; 2007 Sep 01; 30(6):607-13. PubMed ID: 17667524
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of anti-podoplanin rat monoclonal antibody NZ-1 for targeting malignant gliomas.
    Kato Y, Vaidyanathan G, Kaneko MK, Mishima K, Srivastava N, Chandramohan V, Pegram C, Keir ST, Kuan CT, Bigner DD, Zalutsky MR.
    Nucl Med Biol; 2010 Oct 01; 37(7):785-94. PubMed ID: 20870153
    [Abstract] [Full Text] [Related]

  • 19. Pseudomonas exotoxin-based immunotoxins containing the antibody LL2 or LL2-Fab' induce regression of subcutaneous human B-cell lymphoma in mice.
    Kreitman RJ, Hansen HJ, Jones AL, FitzGerald DJ, Goldenberg DM, Pastan I.
    Cancer Res; 1993 Feb 15; 53(4):819-25. PubMed ID: 8428363
    [Abstract] [Full Text] [Related]

  • 20. Isolation and characterizations of a novel recombinant scFv antibody against exotoxin A of Pseudomonas aeruginosa.
    Shadman Z, Farajnia S, Pazhang M, Tohidkia M, Rahbarnia L, Najavand S, Toraby S.
    BMC Infect Dis; 2021 Mar 24; 21(1):300. PubMed ID: 33761869
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.